These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 21388703)
1. Specific peripheral miRNA profiles for distinguishing lung cancer from COPD. Leidinger P; Keller A; Borries A; Huwer H; Rohling M; Huebers J; Lenhof HP; Meese E Lung Cancer; 2011 Oct; 74(1):41-7. PubMed ID: 21388703 [TBL] [Abstract][Full Text] [Related]
2. A chronic obstructive pulmonary disease related signature in squamous cell lung cancer. Boelens MC; Gustafson AM; Postma DS; Kok K; van der Vries G; van der Vlies P; Spira A; Lenburg ME; Geerlings M; Sietsma H; Timens W; van den Berg A; Groen HJ Lung Cancer; 2011 May; 72(2):177-83. PubMed ID: 20832896 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA signatures in peripheral blood mononuclear cells of chronic heart failure patients. Voellenkle C; van Rooij J; Cappuzzello C; Greco S; Arcelli D; Di Vito L; Melillo G; Rigolini R; Costa E; Crea F; Capogrossi MC; Napolitano M; Martelli F Physiol Genomics; 2010 Aug; 42(3):420-6. PubMed ID: 20484156 [TBL] [Abstract][Full Text] [Related]
4. Gene expression networks in COPD: microRNA and mRNA regulation. Ezzie ME; Crawford M; Cho JH; Orellana R; Zhang S; Gelinas R; Batte K; Yu L; Nuovo G; Galas D; Diaz P; Wang K; Nana-Sinkam SP Thorax; 2012 Feb; 67(2):122-31. PubMed ID: 21940491 [TBL] [Abstract][Full Text] [Related]
5. miRNA expression and its clinical implications for the prevention and diagnosis of non-small-cell lung cancer. Gao W; Xu J; Shu YQ Expert Rev Respir Med; 2011 Oct; 5(5):699-709. PubMed ID: 21955239 [TBL] [Abstract][Full Text] [Related]
6. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Ng EK; Chong WW; Jin H; Lam EK; Shin VY; Yu J; Poon TC; Ng SS; Sung JJ Gut; 2009 Oct; 58(10):1375-81. PubMed ID: 19201770 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resection. Patnaik SK; Kannisto E; Knudsen S; Yendamuri S Cancer Res; 2010 Jan; 70(1):36-45. PubMed ID: 20028859 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA expression profiles in human colorectal cancers with liver metastases. Lin M; Chen W; Huang J; Gao H; Ye Y; Song Z; Shen X Oncol Rep; 2011 Mar; 25(3):739-47. PubMed ID: 21174058 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA classifiers for predicting prognosis of squamous cell lung cancer. Raponi M; Dossey L; Jatkoe T; Wu X; Chen G; Fan H; Beer DG Cancer Res; 2009 Jul; 69(14):5776-83. PubMed ID: 19584273 [TBL] [Abstract][Full Text] [Related]
11. Analysis of serum micro-RNAs as potential biomarker in chronic obstructive pulmonary disease. Akbas F; Coskunpinar E; Aynaci E; Oltulu YM; Yildiz P Exp Lung Res; 2012 Aug; 38(6):286-94. PubMed ID: 22686440 [TBL] [Abstract][Full Text] [Related]
12. MicroRNAs in breast cancer pathogenesis. Götte M Minerva Ginecol; 2010 Dec; 62(6):559-71. PubMed ID: 21079577 [TBL] [Abstract][Full Text] [Related]
13. Blood-based gene expression signatures in non-small cell lung cancer. Zander T; Hofmann A; Staratschek-Jox A; Classen S; Debey-Pascher S; Maisel D; Ansén S; Hahn M; Beyer M; Thomas RK; Gathof B; Mauch C; Delank KS; Engel-Riedel W; Wichmann HE; Stoelben E; Schultze JL; Wolf J Clin Cancer Res; 2011 May; 17(10):3360-7. PubMed ID: 21558400 [TBL] [Abstract][Full Text] [Related]
14. Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis. Guo L; Liu Y; Bai Y; Sun Y; Xiao F; Guo Y Eur J Cancer; 2010 Jun; 46(9):1692-702. PubMed ID: 20371173 [TBL] [Abstract][Full Text] [Related]
15. Alteration of miRNA profiles by ionizing radiation in A549 human non-small cell lung cancer cells. Shin S; Cha HJ; Lee EM; Lee SJ; Seo SK; Jin HO; Park IC; Jin YW; An S Int J Oncol; 2009 Jul; 35(1):81-6. PubMed ID: 19513554 [TBL] [Abstract][Full Text] [Related]
16. Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation. Cho WC; Chow AS; Au JS Eur J Cancer; 2009 Aug; 45(12):2197-206. PubMed ID: 19493678 [TBL] [Abstract][Full Text] [Related]